Kv3.4 is overexpressed in both the early and advanced stages of this neurodegenerative disease, and the up-regulation of Kv3.4 leads to altered electrical and synaptic activity that may underlie the neurodegeneration observed in Alzheimer’s disease13. Here, KCNC4 is linked to neurodegenerative disease.